Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co’s Jürgen Polifka joins Cardiome

Will lead commercialisation in Europe of atrial fibrillation treatment Brinavess

Jürgen Polifka has left his role at Merck and Co to join Canada-based biopharma Cardiome as general manager, sales and marketing Europe.

Polifka was most recently regional marketing leader hospital care at Merck for a portfolio of products, including atrial fibrillation treatment Brinavess (vernakalant), which Cardiome is due to assume commercialisation responsibility for in Europe.

In total, Polifka spent more than 16 years at Merck, serving in several senior roles, such as product manager, marketing and sales manager, director hospital and specialty products and brand leader. During this time, he covered both infectious disease and cardiovascular care at different stages.

"We are extremely pleased to have Dr Polifka join Cardiome at such a critical time in its history," said Karim Lalji, Cardiome's chief commercial officer.

"His personal experience with Brinavess at MSD and deep understanding of the European hospital and cardiovascular markets will be invaluable as Cardiome assumes commercialisation responsibility for Brinavess in Europe."

9th April 2013

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening...
Meeting1
Reimagining strategy development for a hybrid workforce
By Janice MacLennan...